Cambridge Investment Research Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,380
Closed -$70K 3798
2025
Q2
$70K Sell
11,380
-1,250
-10% -$8.31K ﹤0.01% 3512
2025
Q1
$96K Sell
12,630
-500
-4% -$4.18K ﹤0.01% 3354
2024
Q4
$126K Sell
13,130
-5,280
-29% -$41.1K ﹤0.01% 3289
2024
Q3
$109K Sell
18,410
-2,004
-10% -$13.3K ﹤0.01% 3256
2024
Q2
$141K Buy
+20,414
New +$144K ﹤0.01% 3111
2021
Q3
Sell
-10,520
Closed -$132K 3152
2021
Q2
$132K Buy
+10,520
New +$114K ﹤0.01% 2927
2019
Q3
Sell
-10,166
Closed -$41K 2382
2019
Q2
$41K Buy
+10,166
New +$41K ﹤0.01% 2153
2018
Q4
Sell
-78,986
Closed -$488K 2227
2018
Q3
$488K Sell
78,986
-3,400
-4% -$15.4K ﹤0.01% 1462
2018
Q2
$526K Sell
82,386
-3,353
-4% -$23.9K 0.01% 1372
2018
Q1
$598K Buy
85,739
+18,953
+28% +$221K 0.01% 1246
2017
Q4
$842K Buy
66,786
+3,680
+6% +$44.9K 0.01% 989
2017
Q3
$750K Buy
63,106
+8,855
+16% +$131K 0.01% 989
2017
Q2
$812K Buy
54,251
+2,000
+4% +$26.7K 0.01% 914
2017
Q1
$498K Buy
+52,251
New +$441K 0.01% 1075
2014
Q4
Sell
-10,600
Closed -$76K 1447
2014
Q3
$76K Buy
+10,600
New +$73.9K ﹤0.01% 1410

Other funds holding MDXG

Cambridge Investment Research Advisors's MDXG Position: Q3 2025 in Review

Cambridge Investment Research Advisors sold out of MiMedx Group (MDXG) in Q3 2025, closing a stake of 11,380 shares — an estimated $70K sold.

Cambridge Investment Research Advisors first reported a position in MDXG in Q3 2014 and held it in 15 quarters. The position peaked at $842K in Q4 2017. 231 funds tracked by Wall St. Rank hold MDXG as of Q3 2025.

  • Cambridge Investment Research Advisors reported no remaining MiMedx Group position as of Q3 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,380 MiMedx Group shares in Q3 2025, an estimated $70K.
  • Cambridge Investment Research Advisors first reported a position in MiMedx Group in Q3 2014 and held it in 15 quarters.
  • Cambridge Investment Research Advisors's MiMedx Group position peaked at $842K in Q4 2017.
  • 231 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.